Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up

Rheumatology International

Volumn 27, Issue 11, 2007, Pages 1031-1039

  Kötter, Ina ^a   Neuscheler, Daniela ^a   Günaydin, Ilhan ^a   Wernet, Dorothee ^a   Klein, Reinhild ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

ANA; Connective tissue disease; Fibromyalgia; Prevalence; SLE

Indexed keywords

ANTINUCLEAR ANTIBODY; DNA ANTIBODY; THYROID ANTIBODY;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BLOOD DONOR; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROMYALGIA; FOLLOW UP; HUMAN; IMMUNOASSAY; IMMUNODIFFUSION; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RAT; RETROSPECTIVE STUDY; RISK; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FIBROMYALGIA; FOLLOW-UP STUDIES; GERMANY; HEALTH SURVEYS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 34547830256     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0413-7     Document Type: Article

References (76)

1. 1990 classification criteria of fibromyalgia from the American College of Rheumatology. Report of the multicenter criteria committee. Union Med Can 1990 119:272
2. Wallace DJ (1997) The fibromyalgia syndrome. Ann Med 29:9-21
3. Goldenberg DL (1999) Fibromyalgia syndrome a decade later: what have we learned? Arch Intern Med 159:777-785
4. Ledingham J, Doherty S, Doherty M (1993) Primary fibromyalgia syndrome-an outcome study. Br J Rheumatol 32:139-42
5. Russell AS, Percy JS (1994) Disabling fibromyalgia: appearance vs reality. J Rheumatol 21:1580
6. White KP, Harth M, Teasell RW (1995) Work disability evaluation and the fibromyalgia syndrome. Semin Arthritis Rheum 24:371-381
7. Wolfe F, Aarflot T, Bruusgaard D, et al (1995) Fibromyalgia and disability. Report of the Moss international working group on medico-legal aspects of chronic widespread musculoskeletal pain complaints and fibromyalgia. Scand J Rheumatol 24:112-118
8. Bennett RM (1996) Fibromyalgia and the disability dilemma. A new era in understanding a complex, multidimensional pain syndrome. Arthritis Rheum 39:1627-1634
9. Buchwald D, Pearlman T, Umali J, Schmaling K, Katon W (1996) Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. Am J Med 101:364-70
10. Wolfe F, Potter J (1996) Fibromyalgia and work disability: is Fibromyalgia a disabling disorder? Rheum Dis Clin North Am 22:369-391
11. Noller V, Sprott H (2003) Prospective epidemiological observations on the course of the disease in fibromyalgia patients. J Negat Results Biomed 2:4
12. Hudson JI, Pope HG (1994) The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Baillieres Clin Rheumatol 8:839-856
13. Dohrenbusch R, Gruterich M, Genth E (1996) Fibromyalgia and Sjogren syndrome-clinical and methodological aspects. Z Rheumatol 55:19-27
14. Tishler M, Barak Y, Paran D, Yaron M (1997) Sleep disturbances, fibromyalgia and primary Sjogren's syndrome. Clin Exp Rheumatol 15:71-74
15. Morand EF, Miller MH, Whittingham S, Littlejohn GO (1994) Fibromyalgia syndrome and disease activity in systemic lupus erythematosus. Lupus 3:187-191
16. Middleton GD, McFarlin JE, Lipsky PE (1994) The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 37:1181-1188
17. Al-Allaf AW, Ottewell L, Pullar T (2002) The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-up. Clin Rheumatol 21:472-477
18. Dinerman H, Goldenberg DL, Felson DT (1986) A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. J Rheumatol 13:368-373
19. Bridges AJ (1993) Fibromyalgia, antinuclear antibodies and clinical features of connective tissue disease. Clin Exp Rheumatol 11:696-697
20. McLain DA (1998) Clinical features of ANA-positive and ANA-negative patients with fibromyalgia. J Clin Rheumatol 4:292-293
21. Calvo-Alen J, Bastian HM, Straaton KV, Burgard SL, Mikhail IS, Alarcon GS (1995) Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at a large tertiary care center. Arthritis Rheum 38:1475-1484
22. Ritts RE, Mackay IR (1979) WHO handbook of immunological tecjniques: World Health Organisation
23. Tan EM, Kunkel HG (1966) Characteristics of a soluble nuclear antigen preparation with sera of patients with systemic lupus erythematosus. J Immunol 96:464
24. Tan EM, Cohen H, Fries JF et al (1982) The 1982 Revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
25. Yunus MB, Hussey FX, Aldag JC (1993) Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study. J Rheumatol 20:1557-1560
26. Bengtsson A, Ernerudh J, Vrethem M, Skogh T (1990) Absence of autoantibodies in primary fibromyalgia. J Rheumatol 17:1682-1683
27. Silverman S, Gluck O, Silver D et al (1996) The prevalence of autoantibodies in symptomatic and asymptomatic patients with breast implants and patients with fibromyalgia. Curr Top Microbiol Immunol 210:317-322
28. Bridges AJ, Anderson JD, Burns DE, Kemple K, Kaplan JD, Lorden T (1996) Autoantibodies in patients with silicone implants. Curr Top Microbiol Immunol 210:277-282
29. Klein R, Berg PA (1994) A comparative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome. Clin Investig 72:541-549
30. Forslid J, Heigl Z, Jonsson J, Scheynius A (1994) The prevalence of antinuclear antibodies in healthy young persons and adults, comparing rat liver tissue sections with Hep-2 cells as antigen substrate. Clin Exp Rheumatol 12:137-141
31. Petri M, Karlson EW, Cooper DS, Ladenson PW (1991) Autoantibody tests in autoimmune thyroid disease: a case-control study. J Rheumatol 18:1529-1531
32. Mutasim DF, Adams BB (2000) A practical guide for serologic evaluation of autoimmune connective tissue diseases. J Am Acad Dermatol 42:159-174
33. Kavanaugh AF, Tomar R, Reveille JD, Solomon DH, Homburger HA (2000) Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 124:71-81
34. Hayashi N, Kawamoto T, Mukai M et al (2001) Detection of antinuclear antibodies by use of an enzyme immunoassay with nuclear Hep-2 cell extract and recombinant antigens: comparison with immunofluorescence assay in 307 patients. Clin Chem 47:1649-1659
35. Pandey JP, Fudenberg HH, Ainsworth SK, Loadholt CB (1979) Autoantibodies in healthy subjects of different age groups. Mech Ageing Dev 10:399-404
36. Tan EM, Feltkamp TE, Smolen J, Butcher B, Dawkins R, Fritzler MJ (1997) Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 40:1601-1611
37. Vaile JH, Dyke L, Kherani R, Johnston C, Higgins T, Russell AS (2000) Is high titre ANA specific for connective tissue disease? Clin Exp Rheumatol 18:433-438
38. De Vlam K, De Keyser F, Verbruggen G, et al (1993) Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol 11:393-397
39. Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ (1985) Antinuclear, anticytoplasmatic, and anti-Sjogren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol 36(1):120-128
40. Craig WY, Ledue TB, Johnson AM, Ritchie RF (1999) The distribution of antinuclear antibody titres in "normal" children and adults. J Rheumatol 26:914-919
41. Moulias R, Proust J, Wang A et al (1984) Age-related increase in autoantibodies. Lancet 1:1128-1129
42. Vrethem M, Skogh T, Berlin G, Ernerudh J (1992) Autoantibodies versus clinical symptoms in blood donors. J Rheumatol 19:1919-1921
43. Bastian HM, Amos M, Mikhail IS (1996) Serological characterisation of patients with ANA-positive fibromyalgia-manifestations using autoantibody ELISA. Arthritis Rheum 39:S274
44. Walz Le Blanc BAE, Gladman DD, Urowitz MB (1994) Serologically active clinically quiescent systemic lupus erythematosus: predictors of clinical flares. J Rheumatol 21:2239-2241
45. Petri M (1995) Clinical features of systemic lupus erythematosus. Curr Opin Rheumatol 7:395-401
46. Aho K, Koskela P, Mäkitalo R, Heliovaara M, Palosuo T (1992) Antinuclear antibodies heralding the onset of systemic lupus erythematosus. J Rheumatol 19:1377-1379
47. Smart PA, Waylonis GW, Hackshaw KV (1997) Immunologic profile of patients with fibromyalgia. Am J Phys Med Rehabil 76:231-234
48. Dijkstra S, Nieuwenhuis EJ, Swaak AJG (1999) The prognosis and outcome of patients referred to an outpatient clinic for rheumatic diseases characterised by the presence of antinuclear antibodies (ANA). Scand J Rheumatol 28:33-37
49. Arbuckle M, McClain MT, Rubertone MV et al (2003) Development of autoantibodies before the cllinical onset of systemic lupus erythematosus. N Engl J Med 349:1526-1533
50. Vlachoyiannopoulos PG, Tzayara V, Dafni U, Spanos E, Moutsopoulos HM (1998) Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic. J Rheumatol 25:886-891
51. Deane PM, Liard G, Siegel DM, Baum J (1995) The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. Pediatrics 95:892-895
52. Myckatyn SO, Russell AS (2003) Outcome of positive antinuclear antibodies in individuals without connective tissue disease. J Rheumatol 30:736-739
53. Swaak AJG, Smeenk RJ (1985) Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA). Ann Rheum Dis 44:245-251
54. Yadin O, Sarov B, Naggan L, Slor H, Shoenfeld Y (1989) Natural autoantibodies in the serum of healthy women - a five year follow-up. Clin Exp Immunol 75:402-406
55. Bengtsson A, Backman E, Lindblom B, Skogh T (1994) Long term follow-up of fibromyalgia patients: clinical symptoms, muscular function, laboratory tests - an eight year comparison study. J Musculoskelet Pain 2:67-80
56. Bonafede RP, Downey DC, Bennett RM (1995) An association of fibromyalgia with primary Sjogren's syndrome: a prospective study of 72 patients. J Rheumatol 22:133-136
57. Gran JT (2002) Diagnosis and definition of primary Sjogren's syndrome. Scand J Rheumatol 31:57-59
58. Vivino FB, Gala I, Hermann GA (2002) Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol 29:938-944
59. Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554-556
60. Buskila D, Press J, Abu-Shakra M (2003) Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications. Clin Rev Allergy Immunol 25:25-28
61. Aaron LA, Buchwald D (2001) A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 134:868-881
62. Wolfe F (1999) Determinants of WOMAC function, pain and stiffness scores: evidence for the role of low back pain, symptom counts, fatigue and depression in osteoarthritis, rheumatoid arthritis and fibromyalgia. Rheumatology (Oxford) 38:355-361
63. Wolfe F, Hawley DJ, Wilson K (1996) The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 23:1407-1417
64. Hidding A, van Santen M, De Klerk E et al (1994) Comparison between self-report measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia. J Rheumatol 21:818-823
65. Martinez-Lavin M (2001) Overlap of fibromyalgia with other medical conditions. Curr Pain Headache Rep 5:347-350
66. Bennett R (1997) The concurrence of lupus and fibromyalgia: implications for diagnosis and management. Lupus 6:494-499
67. Alarcon GS (1997) Arthralgias, myalgias, facial erythema, and a positive ANA: not necessarily SLE. Cleve Clin J Med 64:361-364
68. Martinez-Lavin M, Leon A, Pineda C, Amogo MC, Hermosillo AG (1999) The dysautonomia of fibromyalgia may simulate lupus. J Clin Rheumatol 5:332-334
69. Gunaydin I, Terhorst T, Eckstein A, Daikeler T, Kanz L, Kotter I (1999) Assessment of keratoconjunctivitis sicca in patients with fibromyalgia: results of a prospective study. Rheumatol Int 19:7-9
70. Rhodus NL, Fricton J, Carlson P, Messner R (2003) Oral symptoms associated with fibromyalgia syndrome. J Rheumatol 30:1841-1845
71. Price EJ, Venables PJ (2002) Dry eyes and mouth syndrome-a subgroup of patients presenting with sicca symptoms. Rheumatology (Oxford) 41:416-422
72. Barton A, Pal B, Whorwell PJ, Marshall D (1999) Increased prevalence of sicca complex and fibromyalgia in patients with irritable bowel syndrome. Am J Gastroenterol 94:1898-1901
73. Wright M (2002) Widespread body pain and mortality. Diagnosing fibromyalgia stops doctors from thinking. BMJ 324:300
74. Fitzcharles MA, Esdaile JM (1997) The overdiagnosis of fibromyalgia syndrome. Am J Med 103:44-50
75. Ohtsuka T, Tamura T, Yamakage A, Yamazaki S (1998) The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease. Br J Dermatol 38:757-764
76. Egner W (2000) The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 53:424-432